Heather D. Turner

Insider Reports History

Location
12481 High Bluff Drive, Suite 160, San Diego, CA
Signature
/s/ Marc Panoff, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Heather D. Turner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LB PHARMACEUTICALS INC Chief Executive Officer, Director Employee Stock Option (Right to Buy) 972K Sep 10, 2025 Direct
Lyell Immunopharma, Inc. Chief General Counsel Option (right to buy) 300K Mar 16, 2022 Direct
Terns Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 45K Jun 11, 2025 Direct

Insider Reports Filed by Heather D. Turner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LBRX LB PHARMACEUTICALS INC Sep 10, 2025 5 $0 4 Sep 12, 2025 Chief Executive Officer, Director
LBRX LB PHARMACEUTICALS INC Sep 10, 2025 0 $0 3 Sep 10, 2025 Chief Executive Officer, Director
TERN Terns Pharmaceuticals, Inc. Jun 11, 2025 1 $0 4 Jun 12, 2025 Director
TERN Terns Pharmaceuticals, Inc. Nov 18, 2024 1 $0 4 Nov 19, 2024 Director
TERN Terns Pharmaceuticals, Inc. Nov 18, 2024 0 $0 3 Nov 19, 2024 Director
LYEL Lyell Immunopharma, Inc. Mar 16, 2022 1 $0 4 Mar 18, 2022 Chief General Counsel
LYEL Lyell Immunopharma, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Chief General Counsel